Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-47,248
Closed -$3.62M 150
2021
Q4
$3.62M Buy
47,248
+2,633
+6% +$194K 1.34% 31
2021
Q3
$3.29M Buy
44,615
+1,460
+3% +$109K 1.5% 21
2021
Q2
$2.88M Buy
+43,155
New +$2.89M 1.41% 21

Other funds holding HOLX

Ellsworth Advisors's HOLX Position: Q1 2022 in Review

Ellsworth Advisors sold out of Hologic (HOLX) in Q1 2022, closing a stake of 47,248 shares — an estimated $3.62M sold.

Ellsworth Advisors first reported a position in HOLX in Q2 2021 and held it in 3 quarters. The position peaked at $3.62M in Q4 2021. 699 funds tracked by Wall St. Rank hold HOLX as of Q1 2022.

  • Ellsworth Advisors reported no remaining Hologic position as of Q1 2022 after selling out during the quarter.
  • Ellsworth Advisors sold 47,248 Hologic shares in Q1 2022, an estimated $3.62M.
  • Ellsworth Advisors first reported a position in Hologic in Q2 2021 and held it in 3 quarters.
  • Ellsworth Advisors's Hologic position peaked at $3.62M in Q4 2021.
  • 699 funds tracked by Wall St. Rank held Hologic as of Q1 2022.

Based on Ellsworth Advisors's 13F filing for Q1 2022, filed 21 Apr 2022.